Sfoglia per Autore
LOW-LEVELS OF THE ANTICOAGULANT ACTIVITY OF PROTEIN-C IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY - AN INHIBITOR OF PROTEIN-C IS PRESENT IN UREMIC PLASMA
1991 E. FAIONI, F. FRANCHI, A. KRACHMALNICOFF, C. VALSECCHI, G. VIGANO, G. REMUZZI, P. MANNUCCI
Plasma protein S in chronic renal insufficiency.
1991 E.M. Faioni, A. Krachmalnicoff, C. Valsecchi, G.L. Viganò, G. Remuzzi, P.M. Mannucci
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
2005 M. Rieger, P.M. Mannucci, J.A. Kremer Hovinga, A. Herzog, G. Gerstenbauer, C. Konetschny, K. Zimmermann, I. Scharrer, F. Peyvandi, M. Galbusera, G. Remuzzi, M. Bohm, B. Plaimauer, B. Lammle, F. Scheiflinger
Considerations on clinical drug research in Italy
2006 L. Tavazzi, S. Garattini, P.M. Mannucci, G. Remuzzi
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats
2007 A. Gianella, E. Nobili, M. Abbate, C. Zoja, P. Gelosa, L. Mussoni, S. Bellosta, M. Canavesi, D. Rottoli, U. Guerrini, M. Brioschi, C. Banfi, E. Tremoli, G. Remuzzi, L. Sironi
The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts
2009 M. Noris, P. Cassis, N. Azzollini, R. Cavinato, D. Cugini, F. Casiraghi, S. Aiello, S. Solini, L. Cassis, M. Mister, M. Todeschini, M. Abbate, A. Benigni, F. Trionfini, S. Tomasoni, C. Mele, C. Garlanda, N. Polentarutti, A. Mantovani, G. Remuzzi
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection
2010 C. Zoja, D. Corna, E. Gagliardini, S. Conti, L. Arnaboldi, A. Benigni, G. Remuzzi
Why rare diseases?
2011 G. Remuzzi, A. Schieppati
Thrombotic microangiopathies: from animal models to human disease and cure
2011 J. Caprioli, G. Remuzzi, M. Noris
Optimizing allocation of kidneys from older donors
2011 P. Ruggenenti, P. Cravedi, G. Remuzzi
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial
2011 P. Ruggenenti, A. Fassi, A.P. Ilieva, I.P. Iliev, C. Chiurchiu, N. Rubis, G. Gherardi, B. Ene Iordache, F. Gaspari, A. Perna, P. Cravedi, A. Bossi, R. Trevisan, N. Motterlini, G. Remuzzi
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility
2011 N. Perico, F. Casiraghi, M. Introna, E. Gotti, M. Todeschini, R.A. Cavinato, C. Capelli, A. Rambaldi, P. Cassis, P. Rizzo, M. Cortinovis, M. Marasà, J. Golay, M. Noris, G. Remuzzi
Cells for treating organ damage: how long will we need them?
2011 A. Benigni, G. Remuzzi
Initial combination therapy for treatment of hypertension
2011 P. Ruggenenti, G. Remuzzi
Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants
2011 B. Imberti, F. Casiraghi, D. Cugini, N. Azzollini, P. Cassis, M. Todeschini, S. Solini, V. Sebastiano, M. Zuccotti, S. Garagna, C.A. Redi, M. Noris, M. Morigi, G. Remuzzi
Targeting the renin angiotensin system in dialysis patients
2011 P. Cravedi, G. Remuzzi, P. Ruggenenti
Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives
2011 M. Abbate, P. Cravedi, I. Iliev, G. Remuzzi, P. Ruggenenti
Aging and the kidney
2011 N. Perico, G. Remuzzi, A. Benigni
The remission clinic approach to halt the progression of kidney disease
2011 P. Ruggenenti, A. Remuzzi, G. Remuzzi, E. Perticucci, R. Trevisan, A. Dodesini, V. Gambara, B. Ene Iordache, S. Carminati, N. Rubis, G. Gherardi, A. Perna, P. Cravedi
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study
2011 P. Cravedi, M.C. Sghirlanzoni, M. Marasà, A. Salerno, G. Remuzzi, P. Ruggenenti
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile